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Abstract
Chronic liver disease has globally risen mainly due to a prevalent Hepatitis C Virus (HCV) infection 
rate and an epidemic of obesity. It is estimated by the year 2030, 2.2 billion people around the 
world will be overweight and 1.1 billion people will be obese. Diabetes and obesity are the main risk 
factors for the development of the metabolic syndrome and in the liver of Non-Alcoholic Fatty Liver 
Disease (NAFLD) which could progress to NASH related cirrhosis and liver malignancy. At present 
there is not effective therapy for NASH besides loss of weight and exercise. Furthermore, optimal 
management of HCC with curative intent includes resection or liver transplantation. Therapies 
that is limited due to the degree of liver dysfunction, medical conditions at the time of diagnosis 
and the scarcity of available liver grafts. The role of cellular lipid management and metabolism 
in human health and disease is taking a center stage. The present overview articulates the current 
pathophysiology of fatty liver disease under the aging processes, potential biological markers of liver 
disease diagnosis and progression and future therapies.
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TAG: Triacylglycerol; TCA: Tricarboxylic Cycle; TNF-α: Tumor Necrosis Alpha; TOR: Target of 
Rapamycin; TIMP: Tissue Inhibitor Of Metalloproteinases; UPR: Unfolded Proteins Response; 4R-
BP: Factor 4E Binding Protein
Introduction
Global burden of chronic liver disease
Chronic liver disease has globally risen mainly due to a prevalent Hepatitis C Virus (HCV) 
infection rate and an epidemic of obesity [1-7]. Between 1990 and 2013, global viral hepatitis deaths 
increased from 0.89 million to 1.45 million and in 2013, viral hepatitis was the seventh leading cause 
of death worldwide [7]. While HBV infection is decreasing in most endemic areas due to successful 
vaccination policies, HCV infection lacks the benefits of a vaccine [7]. Even though HVC antiviral 
therapies recently introduced in clinical practice are highly successful, its implementation is limited 
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due to access and/or financial constraints. Morphological studies in 
HCV showed hepatocyte lipid accumulation similar to the one that 
occurs in obesity.
It is estimated by the year 2030, 2.2 billion people around the 
world will be overweight and 1.1 billion people will be obese [8,9]. In 
addition, 36.1% of adult men and 32.4% of adult women had metabolic 
syndrome in 2010 [10]. Obesity represents the core component of 
the metabolic syndrome, a cluster of metabolic disarrangements 
including dyslipidemias, insulin resistance status, hypertension and 
organ metabolic disturbances such as Non-Alcoholic Fatty Liver 
Disease (NAFLD) and its inflammatory component NASH, diabetes, 
nephropathy, cardiomyopathy and muscle dysfunction [10]. 
Hepatocellular Carcinoma (HCC) has been reported more often in 
non-cirrhotic livers in the background of NASH and its risks factors 
include male gender, older age, cigarette smoking, obesity and insulin-
resistant states [3,4,11]. Overweight and obesity was associated with 
an overall increase in liver cancers of 17% and 89%, respectively 
[2,11,12] and males with a BMI>35 had a 3.5 to 4 times increase in liver 
cancer [12] (Figure 1). Optimal management of HCC with curative 
intent includes resection or liver transplantation. Therapies that is 
limited due to the degree of liver dysfunction, medical conditions at 
the time of diagnosis and the scarcity of available liver grafts. The role 
of cellular lipid management and metabolism in human health and 
disease is taking a center stage [13]. Higher fat consumption, decline 
in physical activity and a progressively aging population are among 
the social and behavioral roots of this phenomenon that add to the 
genetic load [1]. An overview of the role of cell aging and senescence 
in liver metabolic responses to high caloric intake will be performed 
in the pages to follow.
Regeneration, necrosis, apoptosis and senescent: a 
constant changing balance
The liver is a unique organ with an innate ability to regenerate 
through mass compensation to satisfy portal flow and metabolic 
demands [14]. After injury and cell necrosis, immune recall of resting 
cells occurs and activation of oval-precursor cells in conjunction with 
platelets migration switches to a cell division renewal cycle [15,16]. 
Mitosis is more prominent at the peri-portal stem cell niche site (zone 
1) assuring clonal expansion until reaching zone 3 (peri-central vein) 
[15,16]. In health, liver mass homeostasis is closely regulated through 
a delicate balance among regeneration, apoptosis (programmed cell 
termination) and senescence. During states of acute liver injury, the 
pendulum moves towards a regenerative and repair phase, however, 
during chronic states of liver injury collagen synthesis and deposition 
persists leading to organ fibrosis. In addition, natural processes of 
organ aging play a main role in organ response to both acute and 
chronic injuries. Primary cell life span is determined by a limited 
number of cell duplications, the so called Hayflick limit [17]. After 
such limited divisions, cells enter a state of cell replicative senescence 
which is believed to be triggered by shortening of telomere ends. 
Replicative cellular senescence is a stable form of cell arrest 
characterized by a lack of cell proliferation activity and apoptosis 
resistance mediated through a lack of mitogen response even though 
the cells remain metabolically active. On the other hand, cells can be 
induced to a senescence status by a variety of cellular stressors such 
as DNA damage, UV light, radiation, oncogene activation, increased 
H2O2 production and heat stress [17,18]. Senescent cells undergo 
morphological changes as they acquire an enlarged and flattened 
morphology, in addition to an increase expression of the Senescence 
Associated markers ß-Galactosidase (SA-ß-GAL), an accumulation 
of the Senescence Associated Heterochromatic Foci (SAHF) and 
DNA damage foci, and the expression of the Senescence Associated 
Secretary Phenotype (SASP) [18]. Senescent status is achieved and 
maintained by active signaling of p53, a tumor suppressor gene that 
exercises its effects through activation of p21, a potent cell cycle 
inhibitor, and the p16-retinoblastoma protein [18]. Cells induced into 
an irreversible cell cycle arrest at the G1 phase will undergo metabolic 
disturbances with an increase Reactive Oxygen Species (ROS) 
production, decrease Adenosine Triphosphate (ATP) synthesis and 
accumulation of lipofuscin [17].
Changes in the content of daily oral intake can influence life span 
and thus cell aging. The cell death-inducing DNA fragmentation 
factor α-subunit-like effector A (Cidea) is a transcriptional coactivator 
implicated in lipid accumulation, cell stress and cell aging. Authors 
showed in rodents, that a high lipid diet up-regulated Cidea with 
hepatic lipid accumulation, cell stress, mitochondrial dysfunction 
and genetic upregulation of aging [19]. Other studies, in support 
of these findings have shown a life span reduction up to 30% in 
genetically obese mice (ob/ob) and this reduction were reversed by 
a caloric restricted diet [19]. Lipid enriched diets are associated in 
humans with DM type 2, HTN and cardiovascular events all of which 
limit life span. Caloric restriction without malnutrition can extend 
life span while caloric excess has the opposite effect [20]. Thus, the 
choice of oral intake has a profound impact on life span.
The free radical hypothesis of cell aging still remains the most 
reasonable in the induction and maintenance of the senescent status 
[17,21]. ROS, reactive nitrogen sp., and lipid peroxide are important 
regulators of cell signaling that provides reliable maintenance of 
cellular components, support redox-state and regulate the function 
of highly metabolic active cells as in hepatocytes and immune cells 
[20,21]. ROS in excess from over-oxidation of lipids, proteins, nucleic 
acids and other macromolecules is associated with a violation of their 
functional activity, reactions that if they last through the cell cycle 
can lead to permanent cell dysfunction and/or accelerated aging 
cell process. Thus, an excess of food intake in form of continuous 
lipid charge will test the oxi-redox systems that keeps the fragile 
mitochondrial equilibrium in balance. Continuous metabolic 
stress changes the equilibrium towards lower levels of antioxidants 
(glutathione sp.) with further increase of ROS accelerating processes 
of apoptosis and senescence. Former processes in turn lead to arrest 
of regeneration and activation of Hepatic Stellate Cells (HSC) and 
therefore fibrogenesis (Figure 2A).
Hormonal signaling modulates cellular response to caloric 
intake. Insulin and somatotropic signaling are critically important 
not only in the control of aging and longevity under conditions of 
unlimited food supply but also in mediating the effects of caloric 
restriction on life span. In a rodent model of thyroxine induced aging, 
thermogenesis was directly correlated with increased mitochondrial 
function, increased ROS production, decreased concentration 
of reduced glutathione, reduction in the activity of antioxidants 
enzymes and increased senescent marker expression in the liver as 
well as in other organs [21]. Estrogen influences lipid metabolism 
through nuclear receptors which enhances apoptosis of mutated 
cells, improves mitochondrial function, and decreases the metabolic 
syndrome phenotype [10,22]. Actions this may explain, at least in 
part the constant disparity of overall life expectancy by gender.
Lifestyle changes such as exercise and caffeine supplementation 
have shown to increase the ratio of reduced/oxidized glutathione 
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in liver and muscle tissue in the rodent model [23]. Although liver 
enzymes were identical in experimental and controls groups, plasma 
levels of cytokines associated with inflammation (IL-1ß, IL-6, TNF-α 
and INF-α) and cell aging were found to be significantly decreased in 
the experimental group when compared to controls [23]. It was noted 
that although exercise increased the production of ROS, exercise also 
evoked a beneficial increase in levels of cell antioxidants, and lowered 
levels of oxidative damage when cells were exposed to a second 
injury, i.e. lipid charge. Thus, the concept of exercise inducing gene 
expression of antioxidant enzymes that may protect the cell from 
other insults was called ‘hormesis’ [23]. Although caffeine, a member 
of the methyl-xanthine family increased the ratio of reduced-oxidized 
glutathione, no other markers of cell stress were modified. Perhaps, 
caffeine potentiates further the beneficial effects of exercise.
Liver metabolism in health and disease
The reduced tri-peptide Glutathione (GSH) is the major 
antioxidant in the body responsible for maintaining the intracellular 
redox balance. GSH in plasma represents 90% of the GSH synthesized 
in the liver [24] and aging is associated with a progressive decline in 
the levels of GSH in humans and rodents [25]. Senescent liver cells in 
culture showed elevated ROS leading to a state of chronic oxidative 
stress. In addition, age associated decline in GSH has been linked to 
an activation of neural sphingolipid hydrolase enzyme (NSMase) and 
the accumulation of bioactive ceramide, a precursor of inflammation 
[25]. The availability of L-cysteine is the rate-limiting factor of 
GSH synthesis and oral supplementation of cysteine alleviates GSH 
deficiencies in humans and rodents [25]. GSH deficiency can be 
alleviated by the oral intake of cysteine and its restoration rates appear 
to be age and sex dependent. Older animal models are associated with 
increased cellular stress and an enhanced subcellular injury after heat 
stress associated with an increased iron intracellular deposition [26]. 
These cause damages to mitochondria and lysosomes. Although a 
more precise mechanism of organelle damage was not enunciated, 
iron deposition mediated decrease in transferrin-receptor-1 which 
upregulates the iron storage protein ferritin after heat stress. 
Nevertheless, the synthesis of the iron exporter protein ferroportin 
was delayed [26]. Effect this may explain at least in part, organelle 
damage in the aging cell that occurs after natural oxidants depletion 
(Figure 2B).
A diet enriched in calories and lipids increases free Fatty 
Acids (FA) in plasma obligating cells to protect themselves from 
lipotoxicity or death by either oxidizing FA’s or sequestering them as 
Triacylglycerol (TAG) within Lipid Droplets (LD) [13]. An exercise-
induced transcriptional coactivator PGC-1α appears to play a key 
role in coordinating intramuscular LD-signaling with mitochondrial 
remodeling. TAG within lipid droplets are the major form of energy 
storage in the body (muscle, liver, fat tissue) and a reservoir of 
membrane lipid component. TAG synthesis is initiated by Glycerol-
3-Phosphatase Acetyltransferases (GPAT) at the mitochondrial 
and sarcoplasmic reticulum membranes and it is completed at the 
sarcoplasmic reticulum by the sn-1-Acyl-Glycerol-3-Phosphatase 
Acyltransferase (AGPAT), Phosphatidic Acid Phosphatase (PAP) 
and sn-1, 2-Diacylglycerol Acyltransferase (DGAT) [13]. Synthetized 
LD-TAG is localized preferentially in proximity to mitochondrial 
membranes named “contact zones”. Once TAG’s are released, they 
are mainly used in the mitochondria for ATP synthesis via oxidative 
phosphorylation from the ß-oxidation path. The “athlete paradox” 
states that the accumulation of TAG in the trained and insulin 
sensitive cells is in greater proportion than the TAG accumulation in 
cells from diabetic subjects with insulin resistance. This observation 
supports the hypothesis of mitochondrial dysfunction as a factor of 
TAG accumulation from a sustained lipid charge.
The protein family of Perilipins (PLIN) is associated with LD’s 
and their scaffolding may affect the interaction between TAG and the 
mitochondria [13]. The PLIN family consists of PLIN1 to 5; the most 
common PAT (perilipin/ADRP/TIP47) interacts with LD in different 
proportions. In the liver, down-regulation of PLIN2 promotes a 
reduction of hepatic steatosis and increases insulin sensitivity, albeit 
a reduction in both PLIN2 and PLIN3 cause insulin resistance [13]. 
In the heart, a PLIN5 deficiency causes increased lipid oxidation, 
increased ROS production and decreased cardiac function. In heart 
and skeletal muscle TAG and FA are the main metabolic source of 
energy through the ß-oxidation pathway, suggesting a very tightly 
regulated process from cell storage to mitochondrial metabolic use. 
While TAG may come from LD, FA’s are mainly transported in plasma 
as albumin-bound or as part of the Very Low Density Lipid-protein 
Figure 1: Main causes of End Stage Liver Disease (ESLD) and Hepatocellular Carcinoma (HCC) in USA. Hepatitis C Virus infection (HCV) and obesity are 
the main cause of the Global and Western increase in ESLD and HCC. While prevention relays in stopping virus transmission and implementing programs 
of healthy caloric intake and exercise programs, treatments of established ESLD and its malignant consequence are similar. Nevertheless, the most effective 
surgical treatment, liver transplantation is limited due to scarcity of donors and loco-regional therapies have limited survival effect due to malignant recurrence or 
progression of liver dysfunction.
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(VLDL) complex. Different transmembrane transporter systems are 
involved in their translocation to the inner cell compartment where 
the Long Chain Fatty Acid (LCFA) forms thioesters with coenzyme A 
(CoA). LCFA-CoA can form TAG for storage as LD, or can enter the 
outer mitochondrial membrane where CPT1 catalyzes the reaction of 
LCFA-CoA to LC-acylcarnitine. The former compound can actively 
cross the inner mitochondrial membrane with the exchange of 
carnitine for acylcarnitine. CACT is highly expressed in tissues with 
predominant ß-oxidation metabolism.
The metabolism of FA in the mitochondrial matrix is sequentially 
catalyzed through a ß-oxidation process by four enzyme families: 
acyl-CoA dehydrogenase, enoyl-CoA hydratase, 3-hydroxyacyl-
CoA dehydrogenase and 3-ketoacyl-CoA thyolase. While acyl-
carnitine is converted back to acyl-CoA to enter the TCA cycle, 
dehydrogenases activity shows different affinity for short, medium, 
long and very long FA‘s [13]. Every cycle of ß-oxidation renders 
acyl-CoA and shortens the FA chain by 2 carbons providing the 
equivalents of electron donors NADH and FADH2 which is the 
driving force for the synthesis of ATP. Although the ß-oxidation 
pathway is an effective way of ATP production, an overload of FA 
may play the role of uncoupler that exercises an inhibitory effect on 
the respiratory chain through a proton-phoric effect on the inner 
mitochondrial membrane. This effect results from the implicit effect 
of FA on the mitochondrial membrane permeability by opening of 
the permeability transition pore, which results in the subsequent loss 
of electrical gradient and arrest of the respiratory chain [13]. The 
Figure 2A: Morphological changes observed in the mice model of High Fat Diet (HFD) plus fructose (Western Diet) in the microbiota, fat content tissue and liver. 
Liver cells accumulate FA in form of TG from the spillover of lipid excess in the fat compartment and after saturated the normal processes of liver lipid metabolism.
Figure 2B: Local liver inflammatory response from lipid excess and cell involved in the hepatic ecosystem. Lipotoxicity an addition to increase LPS activates SEC, 
HSC and Kupffer cells inducing more parenchymal cells into senescence and apoptosis and change of the local mielue into an inflammatory microenvironment. 
Continuous HFD decreased further mitochondrial function with lower ATP production, increase collagen deposition and progressive liver fibrosis, liver dysfunction. 
The state of progressive liver fibrosis due to a local and systemic inflammatory state results in an increasing insulin resistance status with the full metabolic 
syndrome phenotype. Its progression results in decompensated ESLD and the development of malignancy.
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progression from NAFLD to NASH [29]. Excess of lipids and fuels 
trigger a low grade inflammatory response in both fat and liver tissues 
that correlates with the impaired insulin responsiveness. TBARS, a 
simple but fair estimate of lipo-peroxidation/malondialdehyde 
(systemic oxidative stress) produced throughout the body was shown 
to be elevated in plasma from NASH patients when compared to 
normal subjects and its levels were correlated with insulin-resistance 
status [29]. The former response involved activation of the c-Jun 
NH2-terminal Kinases (JNK’s), Endoplasmic Reticulum (ER) stress, 
Unfolded Proteins Response (UPR), and the ceramide pathway by 
blocking nuclear factor κB (NF-κB) expression at different levels 
[29]. In liver tissue, HSP70 down-regulates TNF-α and inducible 
Nitric Oxide Synthase (NOS2), genes that increase the inflammatory 
response in rodents. In addition, HSP70 in humans induces apoptosis 
and increases the concentration of cyclopentenone prostaglandins, 
a potent local inhibitor of inflammation. In human liver and fat 
tissues, the suppression of HSP70 was strongly correlated with the 
upregulation of JNK1 and JNK2 [29]. The authors hypothesized 
that the senescence-like state in fat cells have evolved in obese 
individuals as an adaptation to the metabolic overutilization of fat 
cells, supporting the observation that hepatocyte senescence predicts 
NAFLD progression to NASH and to cirrhosis. Patients with different 
grades of ESLD from NASH or HCV had significantly decreased 
levels of glutathione reduced and increased levels of glutathione 
oxidized in plasma when compared to healthy controls [30]. 
Therefore, a continuous increase in the cell oxidative stress consumes 
the antioxidant protective mechanisms and increases the spillage of 
oxidative molecules. Increased oxidative compounds accumulation 
may induce a progressive larger number of liver cells into senescence 
which in turn will enlarge the ASAP component worsening the 
inflammatory environment with further increase of stressors into the 
above concept favors the hypotheses of mitochondrial dysfunction 
from FA overload as the primary step of the insulin resistance state 
in obese patients. Other authors have found no mitochondrial 
respiratory changes in the steatotic liver but in mitochondria from 
skeletal muscle from a rodent model of high fat diet induced obesity 
[27]. Authors have proposed mitochondrial changes are due to an 
adaptation of the mitochondria to the high lipid charge rather than 
a defect per se in its function. No explanation was provided by the 
authors regarding the increase in ROS and inflammatory changes 
observed. Others suggested a protected effect from caloric lipid 
surplus against the development of metabolic dysfunction, as long 
as cells maintained functional adipocyte storage with low levels of 
tissue inflammation [28]. Once adipose storage capacity is saturated, 
fatty excess spills over into other tissues leading to LD accumulation 
with subsequent lipid oxidation and an inflammatory response which 
precedes the metabolic syndrome manifestations [28]. The Delete in 
Breast Cancer-1 (DBC-1) protein is a key regulator of fat storage in 
adipocytes mediated by inhibition of SIRT1. In the DBC-/KO mice 
exposed to HFD, it was observed high plasma levels of FA with no liver 
steatosis, lower expression of senescence cells and increased storage 
of FA in the adipocytes with no development of insulin resistance 
[28]. Thus, DBC-1 protected liver and adipocytes from senescence 
by preservation of the fat compartment function with liver sparing 
and insulin sensitivity. Interestingly, a comparison has been made 
between this rodent model and the so called ‘healthy obese subjects” 
where there is fat accumulation but no signs of metabolic syndrome 
or systemic inflammation.
Metabolism and inflammation
Obesity depresses the anti-inflammatory effects of the Heat Shock 
Proteins (HSP70) pathway, an inhibition that may contribute to the 
Figure 3: Local and systemic responses that occur in the progression of NAFLD to NASH and ESLD associated HCC and their metabolomic print. The Liver local 
progression from NAFLD to NASH is associated with a local inflammatory response that eventually involves several other organs and becomes systemic. The 
systemic inflammatory response is associated with the development of an insulin resistance status and the metabolic syndrome phenotype, HTN, central obesity 
and DM Type II. Continuous liver lipotoxicity decreased mitochondria function, decrease ATP production and enhance the secretion of lipid intermediates toxic 
to CD4 T lymphocytes. All together enhances a process of regenerative stimulus of in majority senescence cells with mitochondrial dysfunction generating at 
some point a metabolic swap of ATP production to the cytosol, which may be associated with a mitochondrial generated apoptotic switch and in an environment 
of progressive fibrosis and therefore low oxygen and nutrients delivery favoring the survival of the already highly mutated cells which in turn have escaped 
physiological cell cycle control and immuno-recognition assuring cell clone growth. Metabolic disturbances precede cell cycle variation and genetic expression 
creating metabolic signatures of liver status in health and disease.
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liver milieu by triggering an activation of local and systemic immune-
regulators (Figure 3).
Hyperglycemia promotes chromatin remodeling and increased 
polyploidy levels in hepatocytes from non-obese diabetic mice; these 
alterations are similar but not identical, to the changes observed in 
hepatocytes from old mice [31]. Genes involved in glycemic control 
and metabolism are also involved in inflammation such as Ppargc1a 
(PGC-1α). It acts on the histone deacetylase SIRT1 as a metabolic 
sensor in hepatocytes and increases gene activation involved in 
the gluconeogenesis pathway [31]. Furthermore, PGC-1α also 
plays a role in lipid metabolism [31]. Through the thyroid receptor 
pathway, it induces the expression of Srb1 (Scavenger receptor B 
member 1), it enhances the uptake of cholesterol esters from High 
Density Lipoproteins (HDL) in the liver and inhibits the expression 
of Srebp-1 (sterol regulatory element-binding transcription factor-1) 
down-regulating fatty acid synthesis [31]. As SASP builds up due 
to an increasing number of cells entering senescence, an increasing 
insulin resistance state starts to develop with its manifestation, 
hyperglycemia which further favors replicative cell arrest.
The fat compartment has emerged not only as an energy 
reservoir but as an endocrine organ capable of modulating metabolic 
states where the adiponectin/leptin ratio determines an anti or 
pro-inflammatory response. Leptin is a 167-aminoacid hormone 
expressed predominantly in adipocytes. Its signaling is an important 
determinant of food intake, adiposity and energy expenditure [32]. In 
the ob/ob mouse, a homozygous mutation in the gene that encodes 
leptin is associated with increased appetite, obesity and an insulin-
resistant state. When leptin was provided to the ob/ob animal, there 
was a dramatic improvement in glucose homeostasis and energy 
metabolism. Although leptin related glucose homeostasis is largely 
conserved in rodents and humans, most subjects with diabetes and 
insulin-resistant states had lower levels of leptin [32]. Adiponectin is 
a protein hormone of 244 amino acids synthesized as a monomer of 
28 kDa to 30 kDa and assembled in various molecular weights: Low 
Molecular Weight (LMW), Medium Molecular Weight (MMW), and 
High Molecular Weight (HMW) oligomers [33,34]. HMW oligomers 
are the major relevant forms in terms of physiological activities of 
adiponectin while, low amounts of HMW oligomers represent an 
independent risk factor for several metabolic pathologies such as 
obesity-related diseases. Adiponectin plays a pivotal role in energy 
metabolism being an insulin-sensitizing hormone and it is involved 
in a wide variety of physiological cellular processes including 
inflammation, immunity and vascular physiology. Adiponectin 
acts through three major functionally distinct and ubiquitously 
expressed receptors, AdipoR1, AdipoR2 and T-cadherin. Adipo-
receptors mediate pleiotropic adiponectin actions through signaling 
mechanisms involving AMPK, ERK1/2, AKT and P38. In addition, 
Polymerase I and Transcription Release Factor (PTRF) regulates 
adipocyte differentiation, perhaps fat cell senescence and thus may 
determine fat compartment expandability, condition that under 
continuous HFD exposure increase the spill-over of FFA to the liver 
in combination to a pro-inflammatory adipokine repertoire [35].
Signaling of energy expenditure and metabolism
Rapamycin has an effect in cell life span with significant changes 
in the liver transcriptome, effects that are more pronounced when 
animals are exposed to caloric restriction [36,37]. In a rodent model, 
rapamycin prevented senescent changes with significant differences 
by gender but with some common genetic pathways, mainly in the 
preservation of mitochondrial function. Those pathways included 
protein ubiquitination, NRF2-mediated oxidative stress response 
and glucocorticoid and OGF-1 signaling [36,37]. Cell culture studies, 
indicated that treatment with rapamycin decreased mitochondrial 
membrane potential, decreased O2 consumption, and increased 
ATP production [36,37]. Other effects from transcriptome pathways 
include a decrease in proteasome activity in parallel with an increase 
in cell autophagy, suggesting protein quality improvement processes 
and increased resistance to oxidative cell stress effects associated with 
reduced cell aging.
The highly conserved Target of Rapamycin (TOR) signaling 
pathway is a central regulator of growth and metabolism in all 
eukaryotic cells. The mammalian TOR complex (mTOR) encompasses 
two structurally and distinct proteins. While the mTORC1 is 
associated with anabolic processes such as protein synthesis, lipid 
synthesis, nutrient uptake and inhibition of catabolic processes 
including autophagy, mTORC2 is insensitive to rapamycin regulated 
protein. mTOR2 becomes activated by a family of kinases like the 
Serum/Glucocorticoid Kinase (SGK) and Protein Kinase C (PKC). 
mTORC1 is up regulated by growth factors, cellular energy status and 
is inhibited by the macrolide rapamycin [36-38]. Protein synthesis 
is one of the most energy demanding cell functions; a favorable 
redox status activates mTORC1 which in turn exercises its actions 
down-stream through the ribosomal protein 6 kinase (S6K) and the 
eukaryotic translation initiation factor 4E Binding Protein (4R-BP) 
[36-38]. Due to the high demand of ATP, mitochondrial function 
regulation is of paramount importance on mTOR signaling pathways. 
Moreover, mitochondrial dysregulation and continuous mTOR 
activation may play a metabolic central role in the transformation and 
survival of cancer cells. Mutated cells with malignant potential may 
shift their bioenergetic state from ATP mitochondrial production 
to cytosol ATP production through the Tricarboxylic Acid (TCA) 
cycle. A connection between mTORC2 and mitochondrial function 
and cancer appears to be dependent through the HK2 pathway [38]. 
Nevertheless, recently mTORC2 has been linked to cytoskeleton 
regulation through the actin remodeling pathway, which has been 
suggested to have an effect on insulin sensitivity/resistance balance 
[36,37]. In the tissue specific raptor knockout mice, mTORC1 signaling 
in adipose tissue negatively affected whole body energy expenditure, 
systemic sensitivity to insulin and thermogenesis [38]. In the same 
animal model, mTORC2 signaling in the adipose tissue was a crucial 
regulator of liver and pancreas metabolism affecting animal growth 
and insulin homeostasis. In addition, mTORC1 and 2 signaling in 
the liver affects systemic glucose and insulin homeostasis mainly due 
to their effects on Akt and hepatic glucose uptake. Interestingly, liver 
tumors in the tissue specific raptor knockout mice, showed a shift 
from glucose to glutamine as the main fuel source, making tumor cells 
glutamine addictive with high expression of mTORC1 and FGF-21. 
Rapamycin treatment may be beneficial as it may inhibit growth on 
glutamine addictive tumors. Some liver transplant programs switch 
their immunosuppression protocol from tacrolimus to rapamycin 
in patients with high risk for HCC recurrence after transplantation. 
However and on retrospective studies, its effect on long term overall 
survival on patients after liver transplantation for HCC, have had 
conflicting results [39,40].
The functional relationship between poly-unsaturated lipid 
metabolism, inflammation and cancer development has been discussed 
in multiple avenues. Cyclooxygenases (COX’s) and Lipoxygenases 
(LOX’s) are enzymatic families that metabolize poly-unsaturated 
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fatty acids. COX is present in two isoforms (COX-1 and COX-2) 
that produce Prostaglandins (PG’s) and thromboxanes, respectively 
[41]. LOXs constitute a family of dioxygenases that insert O2 into 
poly-unsaturated fatty acids with regional specificity [41]. These 
metabolites are biologically active hydroperoxy-eicosatetraenoic 
acids that upon reduction form Hydro-Eicosatetraenoic acids 
(HETE’s), while the metabolism of linoleic acids preferentially results 
in Hydroxyl-Octadecadienoic acids (HODE’s), metabolites known to 
modulate inflammation and carcinogenesis [41]. An excess of poly-
unsaturated fatty acids could enhance a higher production of HETE’s 
and/or HODE’s with an override of pathways that enhances cancer 
development. Hepatic COX-2 overexpression induces spontaneous 
HCC formation in vitro and in mice through Akt, SKT33 and 
mTOR signaling cascades [42]. In the healthy liver, the inhibitor 
of the prostaglandin degrading enzyme 15-PGDH potentiates liver 
regeneration after partial hepatectomy when compared to control 
and sham animals [43]. Thus, prostaglandin active derivatives have 
the potential not only to modulate local inflammatory responses 
but to promote cell regeneration in the healthy cell and potentially 
reversal of cell arrest in the senescent cell.
Metabolism in the liver as a graft
Evidence seems to indicate a peculiar aging pattern for liver grafts 
after transplantation. Biological age of the graft does not correspond 
to its behavior when transplanted to a different environment of a 
younger recipient [44]. One of the most important intracellular 
protease systems is represented by the proteasome, the central 
catalytic unit of the Ubiquitin-Proteasome System (UPS). No 
difference in the accumulation of oxidized proteins and polyubiquitin 
conjugates with maintenance of their proteolytic activity was found 
in liver grafts after transplantation from younger donors to older 
recipient when compared to liver grafts from older donors placed 
into younger recipients. Furthermore, there was an increase of the 
ß5i/α4 ratio, suggesting a shift toward proteasomes containing 
immune-subunits [44]. Thus, it appears older liver grafts transplanted 
in younger recipients switched their biological metabolism to 
resemble the recipient’s metabolic age. However, the pattern of liver 
cell senescence may differ. Liver biopsies, as judged by the senescent 
markers telomerase and SMP-30 from older transplanted livers 
showed histological damage in asymptomatic patients with up to 43% 
and 64% at 5 and 10 years, respectively [45].
In the warm ischemic/reperfusion liver model, Glycogen 
Synthase Kinase 3 (GSK-3) ameliorated liver injury upon reperfusion 
through an energy-dependent mitochondrial mechanism [46]. GSK-
3 is a serine/threonine kinase regulated by inactivation through 
serine phosphorylation. GSK-3 inhibition down regulates the 
opening of Mitochondrial Permeability Transition Pore (MPTP) 
site, preventing leakage of mitochondrial respiratory chain proteins; 
a key step in the activation of caspase dependent apoptosis and 
therefore mitochondrial-dependent cell termination. This effect was 
present in young animals but abrogated in old animals, and a partial 
response was re-established in the older group by glucose infusion 
with hepatic glycogen build up storage [46]. Authors speculated that 
during reperfusion glycogen degradation provides mitochondrial 
fuel in forms of glutamate and α-ketoglutarate maintaining enough 
energy levels that preserve mitochondrial membrane integrity or 
mitohormesis lowering ROS production, factors needed to decrease 
MPTP susceptibility. Former approach in the human was entertained, 
where liver graft glycogen replenishment was performed during the 
donor phase and evaluated upon reperfusion [47,48]. Metabolic 
benefit with improved organ graft function was observed only in 
borderline grafts and the ones with high fat content. Nevertheless, 
the concept of metabolic replenishment with further graft function 
improvement may be refined by strategies of ex-vivo euthermic graft 
perfusion prior implantation [49-56].
The chronically diseased liver
Hepatocyte senescence has been demonstrated in chronic 
liver disease and as many as 80% of hepatocytes show a senescent 
phenotype in advanced liver disease [57]. The effects of insulin 
in the liver cell are mediated through two main cellular pathways: 
the Phosphatidylinositol 3-Kinase (PI3K)-Akt and the Ras-MAP 
Kinase (MAPK) pathways. While both pathways are active in the 
regulation of cellular growth, proliferation and differentiation the 
PI3K-Akt mediates the metabolic actions of insulin. Those actions 
include activation of mTOR1 and its S6 kinase and the inactivation 
of Glycogen Synthase Kinase-3 (GSK3) as well as its AS160 with 
nuclear exclusion of the Forkhead box protein (Fox01) [57]. In 
culture, HepG2 cell lines showed a signaling defect downstream of 
the Akt pathway with an impact upon insulin mediated Fox01 cytosol 
sequestration and AS160 phosphorylation; a cascade that translated 
into insulin resistance of older cells when compared to younger cells. 
Maintenance of the senescent state requires Fox01 transcriptional 
activity of cell cycle inhibitory genes, even in the presence of growth 
factors. Thus, it appears gluconeogenesis and insulin resistance are 
unwanted but unavoidable effects of Fox01 gene, which is involved 
in cell cycle arrest, detoxification of oxygen species, DNA repair and 
gluconeogenesis [57].
FA overload can damage the respiratory chain in the 
mitochondrion through a dual role: As an uncoupler and as an 
inhibitor [13]. Impairment of the key respiratory state 4→3 can 
occur via inhibition of ATP-synthase thereby producing an increase 
production of ROS irrespective of ADP concentration. The concept 
of Redox-Optimized ROS Balance (R-ORB) postulates that ROS 
efflux from the mitochondrion will attain a minimum at intermediate 
values of oxidation, when VO2 reaches a maximum following ADP 
stimulation. Under state 3 respirations, GSH and thioredoxin systems 
are essential for minimizing ROS release from the mitochondria [13]. 
Moreover, mitochondria from cells with chronic liver disease under 
oxidant challenge displayed a two-fold increase in H2O2 emission 
when compared to controls along with a 50% decrease in GSH [13]. 
Since 90% of GSH in plasma is excreted by the liver, glutathione 
sp. could serve as a surrogate of cell/mitochondrial stress and their 
ratio in plasma may reflect overall liver redox balance [24]. In animal 
models of liver malignancy, with or without cirrhosis glutathione 
sp (glutathione reduced-GSH, glutathione oxidized-GSSG and 
ophthalmate) predicted the growth of malignant cells on normal 
livers as early as 14 days after malignant cells implantation and 
differentiated animals with cirrhosis by tumor status (HCC+ vs. HCC-
) [58,59]. Furthermore, glutathione sp. in plasma were part of the 
metabolic signature that discriminated healthy controls and subjects 
after liver transplantation with normal graft function from subjects 
with chronic liver disease (Figure 3). In addition, metabolic prints 
graded patient’s degree of end stage liver disease which correlated 
with the MELD score, and they were able to separate patients with 
cirrhosis by tumor status, i.e. HCC+ vs. HCC- [30].
Others argued mitochondrial dysfunction by FA’s respiratory 
chain uncoupling is incompatible with thermo-regulatory principles 
that governs mitochondrial respiratory chain through energy 
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demand: intracellular lipids will accumulate whenever FA’s supply 
exceeds the energy needs of the cell [13]. While TAG-LD in cells 
from a trained individual increases as the source of energy, in the 
diabetic obese subject TAG-LD are the result of accumulation with 
the subsequent potential overproduction of lipid derived toxins in 
the form of LCFA-CoA, Diacyl-Glicerides (DAG) and ceramide, 
metabolites responsible, at least in part for the development of 
insulin cell resistance [13]. The former theory is attractive in the 
heart and skeletal muscle. In contractile cells, optimal excitation-
contraction coupling requires an optimal energy and O2 supply which 
in turn affects the Ca2+ handling at the Sarcoplasm Reticulum (SR) 
release channels (ryanodine receptors), the SR Ca2+ pumps and the 
sarcolemmal Na+/Ca++ exchanger. The heart at rest beats in average 
100,000 times per day catalyzing about 6 Kg of ATP to ADP. The 
mitochondrion provides the ATP needed for contraction (≈66%) 
and the ATP needed for ion transporting (≈33%) essential for the 
cardiac electrical activity. Thus, the link among lipid supply and 
mitochondrial function, insulin sensitivity/resistance and ion pump 
exchange is established for optimal cardiac function or dysfunction 
in the obese individual [13]. Perhaps, there is no disputing argument 
that lipid oxidation confers a metabolic advantage during starvation 
and exercise, but the role of fuel selection per se in defending against 
metabolic disease and its role in the liver needs further studies.
In liver, cellular senescence is associated with a pro-fibrogenesis 
environment and the relation between advanced liver fibrosis and 
shortening of the cell telomere appears to be consistent [11,60]. 
Telomeres are repetitive DNA sequences (TTAGGG) associated with 
the specialized protein shelterin. They are located at the chromosomal 
end acting as a cap that stabilizes and protect the chromosome from 
erosion and miss-identification as DNA breaks.
During normal cell division, telomeres shorten due to the “end 
replicating problem”: The inability of DNA polymerases to fully 
replicate the 3’ end of chromosomes [61]. Germline cells overcome 
this problem by expressing telomerase, a reverse transcriptase that 
maintains telomere length by synthesizing new DNA sequences at 
the end of the chromosome [60]. The telomerase complex includes a 
reverse transcriptase (TERT) and the RNA component (TERC) [61]. 
In other somatic cells, continuous cell division results in telomere 
shortening which in turn start signaling cell arrest mechanisms, 
i.e. senescence or apoptosis. Failure of cell arrest signaling as in 
p53 silence sparks further cell proliferation with chromosomal 
end-to-end fusions and instability. In addition, exhaustion of liver 
regenerative paths and invested mechanisms of telomere repair 
could be overcome under continuous and chronic cell injury with 
subsequent acceleration of cell senescence and aging. Some studies 
had shown that telomere biology is involved in HCC initiation and 
its progression [60]. Therefore, telomere shortening is a physiological 
marker of cell aging signaling and/or cell arrest preventing further 
cell division; failure of cell arrest may end in chromosomal instability 
and subsequent mutations may favor tumor development [11,61]. In 
fact, the strength of the DNA Damage Response (DDR) in the normal 
cell depends ultimately to the degree of p53 gene regulation: A 
higher p53 response is associated with apoptosis, a lower response is 
associated with cell senescence and a silence p53 response may favor 
tumor development and growth [62]. In addition, a sirtuin (SIRT7) 
showed an in vivo hyperacetylation of p53 and the SIRT7 knockout 
mice suffered among other maladies steatotic liver disease. Sirtuins 
were initially identified in yeast as the Silent Information Regulator 
(SIR). In mammals, SIRT protein family comprises seven distinct 
members involved in cellular survival, senescence and tumorigenesis 
[62]. The SIRT7 knockout mice showed a 2.5 fold increase in the liver 
triglyceride content and an increased accumulation of hepatocyte 
inflammatory markers [62]. Findings that were associated with liver 
cells mitochondrial dysfunction through a deacetylate GABPß1 
mitochondrial protein pathway and with the development of HCC 
through maintaining a deacetylated state of H3K18 at promoters sites 
of many tumor suppressor genes [62].
Lipodystrophic syndromes are rare and heterogeneous diseases, 
genetic or acquired, where partial atrophy is associated with a 
phenotype consistent with insulin-resistant diabetes, dyslipidemia 
and NAFLD. Although the genetic causes of these syndromes are 
largely unknown, most of the monogenic diseases have in common 
primary alterations in the fat tissue consistent with disturbances of the 
adipogenesis process or defects in the formation, maintenance and/
or regulation of the lipid droplet [63]. Acquired syndromes are seen 
mainly after HIV therapy with anti-retroviral agents as zidovudine 
and Stavudine (tNRTl’s). Agents known to render mitochondrial 
toxicity with metabolic disturbances similar to the metabolic 
syndrome seen in obesity, these metabolic adverse effects include 
premature aging associated with impaired prelamin-A maturation 
[63]. Lamin-A alterations could produce fragile nuclear envelopes, 
alter chromatin organization, increase oxidative stress and promote 
premature senescence at the cellular level. The metabolic disturbances 
observed in genetic or acquired lipodystrophic syndromes support the 
hypothesis of a primary fat compartment dysfunction as the source of 
metabolic disturbances, similar to the ones detected in obesity.
Chronic liver disease is associated with an increased translocation 
of intestinal bacteria contributory to the liver inflammatory response 
and may promote the development of HCC [12]. Liposaccharide 
(LPS) produced by Gram + bacteria hosted in intestines from obese 
humans and rodents was associated with the transition of NAFLD to 
NASH and consequently to its progression to cirrhosis and HCC. LPS 
is recognized by the Toll like Receptor 4 (TLR4) which is expressed 
upon cell activation on migrating and local macrophages (Kupffer 
cells). TLR4 is central for the secretion of TNF-ß and IL-6, cytokines 
present in the chronic inflammatory environment that precedes the 
detection of malignancy [12]. Further support to the role of LPS 
was found by maneuvers such as gut sterilization, removal of LPS 
or inactivation of TLR4; maneuvers that diminished tumor growth 
in chronically injured livers [12]. In experimental models, dietary or 
genetic obesity alterations on the gut microbiota increased levels of 
metabolites like Deoxycholic Acid (DCA) that in turn damages DNA. 
The enterohepatic circulation may enhance the concentration of such 
metabolites further by both encouraging the senescent-associated 
secretory phenotype response and favoring a tumor-promoting 
environment.
Cellular senescence
Hepatocytes: In response to parenchymal cell loss, hepatocytes 
restore the physiological liver mass by self-replication [64]. However, 
massive or unending injury may overcome regenerative processes or 
may promote a dysfunctional repair process leading to progressive 
liver fibrosis, development of portal hypertension and eventually liver 
failure. Senescent status was induced in HepG2 cells by exposure to 
H2O2. Its consequences and metabolic activity were interrogated [18] 
and morphological changes were noted with respect to SA-ß-GAL 
and SAF’s expression, cell cycle arrest as well as the upregulation of 
p53, p21 and p16 genes. Regarding cytokine expression, IL-8 was 
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upregulated while IL-6 was downregulated. Disturbances in glucose 
and lipid metabolism were evident with upregulation of growth 
hormone/IGF1 (SOCS2) and glycolysis (PGM2LT). Nonetheless, 
the downregulation of glucogenolysis and gluconeogenesis (G6PC) 
was more prominent. The unsaturation of fatty acids was hyperactive 
(FADS3) with parallel hypo activity of lipoprotein and hepatic 
lipase activity through the Apo-lipoprotein (APC3) system. APC3 
also limits the uptake of chylomicrons by the liver cell. Other fatty 
acid downregulated proteins included SORL1 (involved in the 
uptake of LDL), ACSM2B (a medium-chain fatty-acid-CoA ligase) 
and PHGDH indirectly involved in amino-acid synthesis [18]. In 
addition, senescent cells secreted a variety of bioactive molecules 
including pro-inflammatory cytokines and chemokines that may 
influence extracellular matrix and the microenvironment but as well 
modulate the immune response with the promotion of macrophage 
migration leading to further increase in the inflammatory mielue 
[65]. Monocyte Chemotactic Protein (MCP-1) could provide a signal 
for monocyte recruitment into the liver followed by activation of 
Kupffer cells with the upregulation of death ligands. The expression 
of Fas ligand, TNF-α and TNF-Related Apoptosis Inducing Ligand 
(TRAIL) further aggravates lipo-apoptosis [66]. In addition the FFA 
palmitate increases the expression of TRAIL and abrogation of the 
TRAIL receptor expression suppresses the inflammation induced by 
nutrient excess in mice [66].
Prior assumptions on cellular senescence determined that cell 
cycle arrest was a mechanism to protect the cell towards tumorigenesis. 
Nevertheless, it has been shown that the cell in cell cycle arrest can 
produce pro-inflammatory mediators, the senescence-associated 
secretory phenotype that promotes tumor growth [67]. During 
chronic liver disease, senescent machinery becomes “hijacked” 
perhaps triggering proliferation and transformation of hepatocytes, 
thus, promoting metabolic adaptation which may enhance tumor 
grafting and growth [68,69]. The above metabolic paths could at least 
in part, be mediated by the over expression of the Phosphatase and 
Tensin homologue (PTEN) described in T-leukemia but later shown 
in liver tumors to inhibit the Pentose Phosphatase Pathway (PPP) 
by binding to Glucose-6-Phophodiesterase (G6PD). With no active 
G6DP dimer, cells favor glycolysis with the production of lactate even 
in the presence of oxygen [70].
Aging and senescent liver cells have different genetic paths that 
may converge to similar metabolic traits. Aging liver cells have a 
proliferative response after injury associated with the repression of C/
EBPα, Farnesoid X Receptor (FXR), Telomere Reverse Transcriptase 
(TERT), and a decrease in the Wnt signaling pathway [71,72]. A 
physiological Wnt signaling pathway involves a soluble ligand that 
binds to the Frizzled receptor (Fzd) and the LRP5/6 co-receptor on 
the plasma membrane; this interaction activates the cytoplasmic 
dishevelled protein which inhibits the ß-catenin (Ctnnb1) 
destruction complex (APC, GSK3ß and Axin) by preventing Ctnnb1 
phosphorylation and its subsequent destruction. Stable ß-catenin 
(intact Wnt signaling) trans locates to the nucleus to form a complex 
with Lef and Tcf transcription factors that target genes as c-Myc 
and Cyclin D1. In cell culture and a mice model of HCC, tumor 
growth was ablated by the suppression of N-Myc Downregulated 
Gene1 (NDRG1) expression; it promoted HCC cells to go into cell 
arrest [73]. The induction of senescence on malignant cells was 
accomplished by upregulation of the tumor suppressor genes p53, 
p21 and p16 in addition to decreased phosphorylated Rb. Senescent 
liver cells response to injury included transcription of Nf-kB, Myb, 
Nkx2-1, Nr5a2 and Ep300 factors; proteins known to be involved in 
inflammation, cell differentiation, lipid metabolism and chromatin 
remodeling. In addition, the chronic inflammatory phenotype of 
senescent cells induces telomere dysfunction and accelerates liver cell 
aging [74]. Thus, decreased physiological cell signaling that occurs 
with aging plus stress induced cell senescence may add to the lipid 
toxic microenvironment by promoting a vicious circle that overrules 
redundant mechanisms that prevent uncontrolled cell division. 
Mechanisms that imply both an apoptosis ‘switch” from a pro-
apoptotic to an anti-apoptotic status and a role of the Bcl-2 proteins 
family to determine cellular fate [75].
Cellular event that follows are the activation/repression of 
factors involved in cell proliferation. In the liver cell, the known 
transcriptional shift includes activation of FOXO3, FOXII, E2F1, 
c-jun, C/EBPß, Myb, USF and neutralization of inhibitors of cell 
proliferation such as Rb family and C/EBP family of proteins 
[76]. In C/EBP-S193A mice, failure to stop liver regeneration after 
surgery correlated with the epigenetic repression of C/EBPß, p53, 
FXR, SIRT1, PGC1α and TERT. The repression was performed by a 
protein formed by C/EBPß-HDCAC1 complex which also inhibit the 
promoters of enzymes for glucose synthesis PEPCK and G6P [76]. 
The response of cell cycle engaged hepatocytes and cell cycle arrested 
hepatocytes (senescent cell) to injury is different and it may awake an 
unregulated cell growth on quiescent stem liver cells [76,77].
Cholangiocytes: Cholangiocytes are elongated cells that cover the 
path of actively secreted hepatocyte’s bile, a fluid that is conducted, 
and modified in bile duct radicals that finally reaches the extrahepatic 
biliary ducts. Although cholangiocytes are metabolically very active 
cells involved in the secretion and resorption of water and soluble 
bile components, they are not directly involved in the metabolism 
and/or regulation of biliary lipid species (cholesterol, bile acids and 
phosphatidil-choline vesicles) [78,79]. Oval shaped liver cells may 
differentiate into cholangiocytes with a distinct metabolism and 
perhaps pathway towards malignancy [15,16]. However, obesity 
and hepatitis B/C virus infections are not associated with a higher 
incidence of cholangiocarcinoma.
Hepatic stellate cells (HSC) and Portal myofibroblasts 
(MF)
HSC are quiescent cells that express typical markers of both 
neural cells and adipocytes (glial fibrillary acid protein-GFAP, 
peroxisome proliferator-activated receptor gamma-PPA, and 
adiponectin receptors). They are activated by cytokines, growth 
factors, ROS, damaged cells and apoptotic bodies [64]. In health, MF 
is located adjacent to bile duct epithelia and is the first responder 
to biliary injuries. Upon activation HSC’s acquire a MF phenotype, 
cells that upon phagocytosis of LD and/or apoptotic bodies from 
damaged cells get additional energy and became Fas-ligand and 
TNF-α unresponsive to apoptosis; mechanism in use for increase 
collagen synthesis and deposition [64]. Furthermore, activation of 
the adenosine receptor A2A increases HSC proliferation and inhibits 
death and senescence by down regulation of p53 and Rb through the 
cAMP-PKA/Rac1/p38 MAPK pathway [80]. Activated MF’s express 
CCN1/CYR61, an important regulator of inflammation and wound 
healing. Cystein-rich 61-protein (CCN1/CYR61) is a matrix-cellular 
protein that induces senescence at later stages of wound healing 
by promoting tissue remodeling through fibrogenic cell apoptosis 
and attenuation of TGF-ß signaling [81]. HSC and MF senescent 
fibrogenic cells no longer proliferate, thereby reducing the load of 
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ECM deposition. In addition, senescent fibrogenic cells express an 
increase in the secretion of Metalloproteinases (MTP’s) leading to 
matrix degradation. Apoptotic fragments from HSC and MF are 
cleared by natural killer cells promoting wound healing, the best 
characterized mechanism of fibrogenesis resolution [64,81]. NFκB 
is a key regulator for HSC survival and proliferation by maintaining 
the expression of Mcl-2. Inhibition of NFκB increases HSC apoptosis 
by up-regulation of the JNK pathway. Thus, the activation as well as 
the induction of senescence/apoptosis of HSC/MF is normal wound 
healing mechanisms that promote the establishment of normal organ 
architecture and function with clear paths of initiation and resolution.
During chronic cell injury, such as in a state of high caloric intake 
enriched with lipids, an increase and progressive pool of biologically 
active HSC’s may become prominent [11]. An incremental 
chronic state of fibrogenesis alters hepatic architecture leading to a 
concomitant increase in portal flow resistance, portal hypertension 
and the development of collateral circulation. In addition, HSC’s 
produce a microenvironment with altered Extracellular Matrix 
(ECM) that provides biochemical and mechanical cues to the growth 
and establishment of tumor cells [67]. Nevertheless, since 90% of the 
HCC’s flourish in a highly progressive fibrotic ECM, the question 
raises if it is the changes on the microenvironment that further 
promotes metabolic transformation with an “apoptotic switch” and 
tumor development. Interestingly, progressive liver fibrogenic ECM 
becomes enriched with Vascular Growth Factor (VGF) receptor 
promoting angiogenesis, paving the way for the much needed arterial 
high O2 supply for HCC expansion [67].
The different components of the ECM, cellular and non-cellular 
interact directly and indirectly with malignant cells therefore 
changing the phenotype of the evolving cells that in turn produces 
feedback signals to further adapt the microenvironment to the needs 
of the malignant cell. The mechanical stress arising from the ECM 
constitute the “out-side-in” signaling linking the actin cytoskeleton 
to the microenvironment by increasing intracellular contractile 
forces regulating signaling pathways fundamental to determine cell 
phenotype. In response, the anchored cells expressed adhesions 
molecules and secreted proteins that signals HSC and other ECM 
regulators increasing anchoring sites in response to the “in-side-
out” signaling [67]. Therefore, the metabolic transformation of the 
already stressed parenchymal cells help to choose a path different to 
senescence and necrosis but to a path of unregulated regeneration, 
thus escaping apoptosis. A path, that needs an ECM differentiation to 
assure cell survival in a non-efficient energy redox status.
Sinusoidal endothelial cells (SEC)
SEC’s are specialized endothelial cells that lie flat in the liver 
sinusoids along and in direct contact with the hepatocytes. Through 
their membranes and specialized pores or fenestra passes high 
concentrations of metabolites, proteins and other blood compounds, 
traffic which is regulated by the size of the fenestra. SEC’s play a 
critical role in immune-activation, rolling of T cells, macrophages 
and PMN migration. Liver sinusoidal endothelial cells may be 
affected with age and obesity. SEC from old individuals have impaired 
and reduced expression of VEGF likely due to impaired nuclear 
transport of P-STST3 and P-CREB transcription factors [82,83]. 
In a rodent model of sepsis, endothelial Nitrogen Oxide Synthase 
(eNOS) deficient mice and aging mice had the same mortality and 
mitochondrial dysfunction upon the isolation of SEC mitochondrion 
[84]. In obesity and during early fibrogenesis, SEC loses their fenestra, 
decreasing the exchange of metabolites and increases the secretion of 
several basement membrane components (type IV collagen, perlecan, 
entactin and laminin) [64]. Authors concluded that an endothelial 
base-line dysfunction in the aging animal is manifested by a 
weakened antioxidant response and inappropriate energy production 
from mitochondrial dysfunction due to a tipped-balance of the SEC 
oxi-redox systems when exposed to additional stress. This is seen 
in the obese towards a state of energy depletion and cellular death, 
apoptosis or activation of a pro-coagulant/pro-fibrogenic phase. The 
changes of SEC’s with aging may limit O2 delivery and availability 
to liver cells with its potential effects on mitochondrial function, a 
pro-fibrogenesis state and the promotion of insulin resistance status. 
Changes exaggerated in obesity, implying obesity may promote 
accelerated SEC aging processes. Interestingly, endothelial cellular 
senescence was inhibited in vitro and in the rodent by the activation of 
the Liver X Receptor (LXR), a nuclear receptor involved in the control 
of hepatic lipid and cholesterol metabolism [85]. Furthermore, LXR 
has been shown to play an important role in glucose metabolism, 
cytokine production and anti-inflammatory response.
Three types of SEC’s co-exist in the normal liver sinusoid: Mature 
SEC, SEC progenitors and bone marrow-derived SEC progenitors 
[86]. Mature SEC is gatekeepers of fibrogenesis by maintaining 
HSC in their inactivated state. SEC’s regulate sinusoidal blood flow 
through their action on HSC and thus keep a low portal pressure [86]. 
In addition, mature SEC’s have the largest endocytic capacity in the 
body fulfilling their dual cell clearance capacity (from the arterial/
systemic and portal/gut systems). The liver endocytic function has 
been implicated in a liver-renal axis where the lack of SEC-stabilin-2 
receptors inhibit the clearance of toxic molecules that manifest 
with mild liver fibrosis without liver dysfunction but with renal 
glomerular fibrosis. Not only do SEC’s have many glycoproteins that 
serve as receptors for bacterial epitopes but as receptors for immune-
modulation and pro-coagulant activity. The above mentioned SEC 
functions are at least partially lost at the time of sinusoid capillarization 
[86]. SEC capillarization is characterized by the disappearance of the 
fenestrae, development of a basement membrane and the appearance 
of characteristic markers. This phenomenon happens in chronic 
liver injury and it precedes activation of HSC and sequestration of 
macrophages. The angiogenesis process that follows is mediated by 
VEGF, an angiocrine response that drives neo-vessel formation in 
direct proportion to the degree of the sinusoidal pressure gradient. 
Furthermore, SEC pseudo-capillarization refers to changes that 
occur in endothelial cells associated with aging and senescence. It is 
manifested by a decrease of up to 50% of their fenestrae, development 
of a patchy basement membrane and partial SEC dysfunction [86]. 
Chronic exposure of high fat diet may accelerate aging/senescence of 
SEC, endothelial dysfunction with recruitment of systemic immune 
cells and activation of Kupffer cells inducing HSC into a fibrogenic 
state followed by an angiocrine response that decreases hepatic blood 
flow, O2 delivery, and clearance of toxic molecules. As metabolic 
stress of neighbor hepatic cells already in mitochondrial distress due 
to fat accumulation progresses, a constant and growing inflammatory 
milieu enhances tumor development, immune-recognition failure 
and then progress and spreading of malignant cells.
Interestingly, aging endothelial cells from the fat compartment 
of mice was associated with adipose dysfunction manifested by 
ectopic (liver) fat deposition and adipose tissue fibrosis, increased 
adipose mitochondrial oxygen flux, altered lipid utilization, increased 
tissue oxidative stress and lower gene expression in visceral fat [87]. 
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Nevertheless, and most important, these findings were associated 
with reduce fat tissue vascularity, reduced angiogenic capacity and 
endothelial dependent dilation with reduced Nitric Oxide (NO) 
bioavailability [87]. Limited oxygen mitochondrial availability 
contributes to the pro-oxidative older adipose tissue phenotype that 
can further impair both insulin action and vascular function, a key 
element in local and systemic insulin-resistant related metabolic 
syndromes. Changes that are exaggerated in obesity, implying obesity 
may promote accelerated aging processes in many organs.
Resident liver immuno-cells
The anatomical location of the liver and its dual blood supply 
ensures an optimal exposure of antigens to the hepatic resident 
immune cells not only from nutrients and GI microbiota but from 
systemic compartments, such as the adipose compartment. Kupffer 
cells in concert with NK, CD4+T-cells, and local antigen presenting 
cells modulates the liver immune status. Kupffer cells constitute 80% 
of the tissue fixed macrophages and 20% of the total cell population 
of a normal liver [9]. Their characteristic macrophage activity is 
polarized mainly in portal tracts where the antigen dynamics is higher 
from food and bacteria. Innate macrophages have the potential to 
initiate an inflammatory response of different proportions by up-
regulating adhesion molecules such as ICAM-1, and cytokines as 
TNF-α, IL-1, IL-6, MIP1α, TGF-ß and RANTES. Activation that 
can only lead to antigen presenting cell to cell communication and 
amplification and enrichment of the microenvironment with ROS 
promoting subsequent parenchymal cell apoptosis/necrosis. Natural 
Killer (NK) and CD8+T-cells developed a specific signature in livers 
with NASH from mice under HFD [88]. The depletion of CD8+T-
cells protected murine from NASH progression but not from weight 
gain. In addition, NK T-cells in the liver express markers that 
recognize lipid antigen CD1d [9]. Liver NK cells undergo Thymus 
clonal double deletion but are positive for CD3 and CD56 and 
they were thought to be CD1d independent. Nevertheless, hepatic 
antigen-presenting cells may introduce microbial glycolipid antigens 
to NK cells, stimulating secretion of Th1 or Th2 cytokines which 
subsequently initiates an adaptive response. Hepatic NK cells have as 
well the ability to secrete osteopontin and sonic hedgehog, molecules 
known to promote the transition from NAFLD to NASH [9]. The 
most accepted hypothesis, continuous cell parenchymal damage and 
necrosis adds to a chronic inflammatory environment a dysregulation 
of the cell cycle regenerative process rendering tandem mutations and 
thus malignant cells was challenged [89]. On the NEMO knockout 
mouse, authors were able to develop HCC through a death receptor-
independent FADD signaling pathway. Nevertheless, it wasn’t until 
recently that the link between a metabolic hostile microenvironment, 
immune-recognition failure and HCC presence was established [90]. 
An increase in liver tissue of linoleic acid, a FA selectively toxic to 
CD4+ T-cells had been significantly associated with low CD4+ T cells 
counts and the presence of HCC, in the rodent and human models. 
CD4 (+) T lymphocytes have greater mitochondrial mass than CD8 
(+) T lymphocytes and generate higher levels of mitochondrially 
derived ROS. Disruption of mitochondrial function by linoleic acid, 
a fatty acid accumulated in NAFLD, causes more oxidative damage 
than other free fatty acids such as palmitic acid and mediates selective 
loss of intrahepatic CD4 (+) T lymphocytes. Local metabolic changes 
could alter the immune response to a one that favors malignant cell 
expansion.
In the obesogenic environment, aberrant activation of immune 
cells has emerged as key features of the metabolic syndrome. The 
interaction between the adipose compartment and the liver tissue 
has been hypothesized as a critical interface for nutrient sensing and 
metabolic control [9]. In the rodent model, neutrophils infiltrate the 
adipose compartment as early as three days after starting a high fat 
diet, however its role as well as the role of basophils and eosinophil 
cells has not yet been clarified. Mast cells, which have been observed 
in increasing number, have been implicated in the secretion of IL-6 
and IFN-Ϫ [9]. Moreover, leptin, a hormone secreted specifically by 
adipocytes has been found to be increased during high fat diets and 
upregulated the expression of leptin receptors on NK T-cells. This 
regulation is time sensitive, and chronic leptin stimulation change NK 
cells from an inflammatory like response to a dampned one, favoring 
at long term, in the liver and perhaps in other organs a susceptibility 
to low recognition of no self-cells, impaired anti-tumor surveillance 
and a nest for the flourishing of cancer. The former hypothesis finds 
support in the obese mice, where it was observed a switch from the 
normal Th1 immuno-response to the Th17 immuno-repertoire, 
phenotype that deteriorates autoimmunity [9].
Extracellular matrix (ECM)
The Extracellular Matrix (ECM) is formed by a non-cellular 
component in tissues and organs composed primarily of water, 
proteins and proteoglycans. Components created an intricate 
scaffold where organ cells get structural support with a dynamic and 
continuous traffic of water, ions, metabolites, proteins and cells on 
passant to maintain organ physiology. As such, ECM interactions 
with organ cell components regulate cell differentiation, adhesion, 
proliferation, migration and survival [64]. The collagen family is 
the major fibrillar proteins of the ECM and the body (approx. 30% 
of the total protein contain) [64]. There are three main classes of 
collagen, fibril-forming which include types I, II, III, XI, XXIV 
and XXVII the most common varieties and their role is mainly 
mechanical by conferring tensile strength to both tissue and organs. 
Fibril-Associated Collagens With Interrupted Triple helix (FACIT’s) 
includes type IX, XII, XIV, XIX, XX, XXI and XXII; this subclass 
of proteins don’t form fibrils themselves but bind to the surface of 
pre-existing collagen favoring fibril enlargement. Finally, type III 
collagen serves as anchoring collagen between the epithelial cells 
and the lamina reticularis constituting the basement membrane 
where type IV collagen is most abundant. Non-collagenous proteins 
include fibronectin, tenascin, laminins, fibrillins and matricellular 
proteins. While the former peptides play a major role in cell 
differentiation, cell growth, adhesion and migration, matricellular 
proteins, i.e. thrombospondin-1 and 2, osteonectin, osteopontin and 
cyr-61/Connective Tissue Growth Factor (CTGF) serve mainly as 
a vehicle for cell signaling. Proteglycans are carbohydrate enriched 
proteins which retain large quantities of water regulating the smooth 
trafficking of molecules to and from the cell with numerous signaling 
active sites for growth factors.
The ECM continuous remodeling is a complex process that 
integrates proteins and cellular components from local and distal 
environments [64]. The degradation of ECM proteins is closely 
controlled by Matrix Metalloproteinases (MMP’s), a superfamily of 
zinc-dependent endopeptidases highly regulated by specific inhibitors 
such as the Tissue Inhibitor of Metalloproteinases (TIMP’s). In the 
liver, cellular component involved in collagen synthesis and deposition 
included HSC, MF and vascular smooth muscle cells [64]. In chronic 
liver injury, an override mechanism of collagen deposition regulation 
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promotes massive ECM expansion. The characteristic features of 
abnormal liver fibrogenesis as a consequence of continuous liver 
injury and activation of collagen secreting cells include damage to 
the epithelial/endothelial barrier, recruitment of inflammatory cells, 
secretion of cytokines and other inflammatory mediators, further 
generation of ROS, progressive deposition of collagen with expansion 
of ECM and worsening organ fibrosis and subsequent metabolic 
changes of portal hypertension.
Mitochondrial senescence
The mitochondria, a double membrane cell organelle varies in 
number and its presence is linearly associated with the metabolic 
activity of the organ and its required energy requirements in form 
of ATP. Within the mitochondrial matrix a series of biochemical 
reactions occur. Acetyl-choline primer is reduced through the 
tricarboxylic acid cycle converting glycolysis-derived pyruvate into 
NADH and succinate. The former compounds couple another set of 
reactions at the inner membrane border where the Electron Transport 
Chain (ETC) is present to boil an oxidative phosphorylation process. 
The ETC is composed of five enzymatic complexes (I to V; NADH-
CoQ, succinate-CoQ, CoQ-cytochrome reductases, cytochrome c 
oxidase and ATP synthase, respectively) where NADH is the substrate 
of ETC-C1 and succinate the substrate of ETC-CII [10]. After 
oxidation, electrons are transferred from Complex I to CII to CIII 
and finally to Complex IV where oxygen is reduced to form H2O. The 
electron transport process is coupled to a proton pumping process 
creating a proton gradient between the mitochondrial membranes, 
gradient that is dissipated by Complex V (ATP synthase) through 
ATP synthesis. A control mechanism is created by the “proton leak”, 
mechanism that generates heat instead of ATP [10]. Much of the leak 
is a catalytic reaction generated by the Uncoupling Proteins (UCP’s) 
which play an important role in reducing proton gradient, heat and 
ROS [10]. Mitochondrial aging and senescence are linked to reduced 
ATP production and increase ROS production, i.e. Superoxide (O2-
), Hydrogen Peroxide (H2O2) and Hydroxyl radical (OH-) which 
are mostly produced because electron leakage at the level of CI and 
CIII [17]. Mitochondria function benefit from the role of estrogen 
in plasma through it's binding to the nuclear estrogen receptor that 
enhances a signaling to prevent oxidant stress and also inhibits the 
renin-angiotensin-aldosterone system [10]. Thus, sex differences in 
mitochondrial function may explain the disparity in overall survival 
between men and women, differences that may be taken into account 
during animal models studies.
The reasons why the mitochondrion conserves a cell independent 
genome are not clear, but it is intuitive to imply self-energy regulatory 
processes are united through a fine tune mechanism between energy 
expenditure (ATP use) and energy production (ATP synthesis) 
at every organelle level. It may provide an overall advantage for 
survival of the cell, the organ and entire biological living system. 
The gradual ROS response theory of aging argues a protective role 
of ROS in early life, when cell oxidative damage and ROS production 
are low; however, later in life ROS reaches a level where its beneficial 
effects (as the one observed in dietary restriction and/or exercise) are 
overcome by its detrimental effects elicited by a higher cell oxidative 
stress (as the one observed in high fat diet and sedentary habits) [18]. 
The effects that are amplified include loss of genomic controls (p53), 
microRNA dysregulation, loss of function of Telomerase Reverse 
Transcriptase (TERT) and a lower immune-surveillance status. 
Although the role of p53 in the mitochondrion is not completely 
clear, p53 binds to the Peroxisome proliferator-activated receptor 
Gamma-Coactivator1 alpha and Beta (PGC-1α and ß) fomenting 
their inhibition of expression and therefore downregulated oxidative 
function. In addition, p53 target p16 and p21, factors that triggers G1-
phase cycle arrest by inhibiting cell cycle regulatory kinases Cdk4 and 
Cdk2 [18]. The third known effect of p53 at the mitochondrion level 
is to promote cell apoptosis by increasing mitochondrial membrane 
permeability with leakage of cytochrome proteins, a direct activator 
of the caspase cascade. The function of TERT is highly affected by 
levels of ROS production and its protective patterns are only observed 
with low ROS levels. The role of microRNA in the mitochondrial 
environment remains to be elucidated.
The Mitochondrial Free Radicals Theory of Aging (MFRTA) 
has been the most popular theory to explain the cell aging process 
where increasing production of mitochondrial ROS with lower 
ATP production are the main factors responsible for cell aging and 
corresponding mitochondrial ultra structure changes [17,91]. As 
mentioned, leakage of electrons at the level of CI and CIII transfer are 
larger with age and the higher potential for DNA damage. 8-oxo-7.8-
dihydro-2’deoxyguanosine (8-oxodG) is one of the most abundant 
DNA mutations caused by oxidative conversion to guanosine. 
Furthermore, its accumulation follows an inverse and exponential 
curve against life expectancy in several mammals [17]. Recently, 
it was described that humans with longer longevity have a higher 
content of mitochondrial DNA (mtDNA) per cell in different organs, 
and support the notion of ethnic background on mtDNA influence 
and life span. The frequency of mtDNA mutations occurs at different 
rate depending on the organ. Skeletal and cardiac muscles, liver and 
kidney are more affected by somatic mtDNA mutations compared 
to other organs such as the skin and lung [17]. Furthermore, the 
clonal expansion of mtDNA mutations occurs via a phenomenon 
called genetic drift, a random propagation and expansion of DNA 
mutations occurring at each DNA replication. The drift of mutations 
may be more important in metabolically more active organs that 
require more energy expenditure and therefore more ATP synthesis. 
The expansion of mtDNA mutations may be enhanced not only by its 
duplication and drift but also by a lower state of DNA damage repair 
mechanisms [17]. The Base Excision Repair (BER) process is impaired 
in senescence and aging due to a loss of function to BER associated 
proteins CSA and CSB. Thus, the increase production of ROS creates 
a vicious loop of mtDNA mutations than in turn favor an increase 
production of ROS perpetuating and enhanced organelle dysfunction 
by defective reparative mechanisms. A naturally occurring thymidine 
to cytidine mutation in the mitochondrial stressors tRNAILE gene 
is associated with phenotypes of hypertension, hypercholesterolemia 
and hypomagnesaemia [10]. Furthermore, the DNA A3243G 
mutation causes impaired insulin secretion and polymorphisms in the 
promoter of the UCP2 protein, alterations associated with increased 
incidence of obesity, reduced insulin secretion and DMII [10].
Mitochondrial function may be impaired in chronic high fat 
diet challenge as a result of a decrease in ß-lipid oxidation. Indirect 
evidence showed an accumulation of diacylglycerol and fatty-
Acyl-CoA which in turn activates stress-related serine/threonine 
kinase activity and inhibits glucose transport [10]. Oxidative stress 
contributes further to impaired insulin signaling increasing UCP2 
activity which in turn enhances “proton leak” with uncoupling of 
the glucose metabolism pathway and decreased ATP production. A 
progressive higher lipid peroxidation may favor further oxidative 
stress with DNA damage and low DNA repair by affecting members of 
the Bcl-2 family, triggering an influx of Ca2+ with subsequent opening 
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of the mitochondrial permeability transition pore, cytochrome-c 
leakage to the cytosol and activation of the caspace-3 complex. Cell 
self-digestion and nuclear DNA fragmentation overcomes with the 
typical cell fragments morphology [10]. Alternatively, DNA damaged 
and telomerase shortening results in mutations that may affect 
mitochondrial function to a level of organelle survival but inefficient 
ATP production assuring the “apoptosis switch” and diverting 
biochemical reactions to a cytosolic site for ATP production. The 
later assumption may find some support in the observations that 
tumor development and early growth is favored in low O2 delivery 
zones and that tumor development is associate with increase lactate 
production, the Warburg effect [30,69].
Future directions
Prevention of metabolic syndrome and its health consequences is 
primordial. A healthy diet that is balanced not only in calories but also 
in its components, specially fats and carbohydrates would avoid fat 
storage spillage from a saturated fat body compartment. In addition, 
a substantial use of lean mass through directed exercise will decrease 
further cell, organ and body aging. The central nervous melanocortin 
system forms a neural nutrient sensing network connecting signals 
of metabolic state with centers of the brain that regulates intake 
behaviors and metabolic homeostasis. Central administration of 
α-MSH reduces food intake and may also increase energy expenditure 
resulting in weight loss [92]. Metabolic disturbances in the liver 
render liver cell changes that progress from NAFLD to NASH to 
cirrhosis and malignancy. A non-invasive plasma based monitoring 
of such changes on disease progression and treatment response as 
well as for tumor screening may be possible by metabolomic liver 
prints in the near future [30].
There have been a myriad or reports on compounds that not only 
prevent but reverse cell aging and some even malignant development 
in the animal model [25,93-102]. Curcumin, the major bioactive 
compound of turmeric spice, through its antioxidant and anti-
inflammatory properties has been claimed to retard tumorigenesis 
and diabetes and to modulate lipid metabolism [103]. Furthermore, 
curcumin prevents the development of atherosclerosis and NASH, 
perhaps by the upregulation of a fatty acid binding protein present 
in adipocytes (aP2) but also found in macrophages (FABP-4). This 
protein is a cytosolic protein present in adipocytes and macrophages 
which modulates the trafficking of lipids/cholesterol processes and 
activation of inflammatory mechanisms through CD36 upregulation 
and reduced expression of NF-kß thus, decreasing cytokine secretion 
[103]. Prior studies showed that high fat diet and obesity promoted 
liver tumorigenesis by inducing chronic inflammation through 
the IL6/STAT3 pathway and, STAT3 activated tumors has been 
showed to be more aggressive in humans. Lycopene attenuated HCC 
occurrences in the animal model through downregulation of the 
STAT3 signaling [95]. The aqueous extract of Ligustrum lucidum 
fruit induced apoptosis through the activation of the caspase cascade 
and cellular senescence by upregulation of p21 and downregulation 
of RB phosphorylation [102].
Other molecules with promising cell aging and tumor repression 
properties included the COX-2 and a Na/K/ATP signaling 
mechanisms. Inhibition of 15-Hydroxyprostaglandin Dehydrogenase 
(15-PGDH), a prostaglandin-degrading enzyme, potentiates tissue 
regeneration in multiple organs in mice [43]. In a chemical screen, 
authors identified a small-molecule inhibitor of 15-PGDH that 
increases prostaglandin PGE2 levels in bone marrow accelerating 
hematopoietic recovery in mice receiving a bone marrow transplant. 
It also promoted tissue regeneration in mouse models of colon and 
liver injury. Selective COX-2 products may have rescued telomere 
dysfunction, cell senescence and tissue regenerative potential [74]. 
However, its mechanism and signal transduction remains to be 
determined. pNaKtide is a synthetic peptide that conserves the 
active sequence for the ligand-binding capacity to the ß-subunit of 
the transmembrane Na/K-ATPase. Although the Na/K-ATPase 
mainly exercise its function as an ion exchanger pump vital for 
cell survival, recently it was shown to elicit nuclear signaling that 
regulates mitochondrial function and cell energy production through 
a Src/ERK pathway [104-112]. Furthermore, pNaKtide prevents the 
development of atherosclerosis and fatty liver disease in the HFD 
mice model with significant amelioration of ROS. In addition, it 
down-regulates collagen synthesis and inhibits growth of human 
cancer cells in vitro. Translation of promising compounds to the 
treatment of patients with NAFLD/NASH is expected in the near 
future to further prevent the consequences of advanced liver fibrosis 
and HCC development.
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